Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.3 trillion and total revenue of $123.25 billion.
Market Cap
1.3T
Revenue
123.25B
Profits
-33.64B
PE Ratio
n/a
Profit Margin
-27.30%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.97B | 0.30% | 288,184 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 96.18B | 0.31% | 226,436 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 88.57B | -2.00% | 2,955,656 | 2.53B |
| 4 | ARGX | argenx SE | 60.99B | 0.61% | 159,965 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.46B | -0.26% | 57,857 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.58B | -0.43% | 868,942 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 36.57B | -1.87% | 956,703 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.60B | 1.19% | 944,696 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.69B | 0.15% | 1,655,934 | 41.08M |
| 10 | INSM | Insmed Incorporated | 27.12B | 2.05% | 959,030 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.64B | -0.07% | 361,374 | 6.01B |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.59B | -2.34% | 655,727 | 5.01B |
| 13 | BNTX | BioNTech SE | 21.47B | 1.16% | 445,205 | 2.75B |
| 14 | ASND | Ascendis Pharma A/S | 17.99B | -0.41% | 235,499 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.66B | -1.07% | 470,787 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.62B | 0.77% | 108,231 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.18B | -0.47% | 342,442 | 945.54M |
| 18 | TECH | Bio-Techne Corporation | 11.44B | 0.03% | 999,118 | 1.23B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.31B | 1.99% | 443,956 | 3.66B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 11.26B | -1.54% | 486,132 | 1.80B |
| 21 | MTRI | Mentari Therapeutics, Inc. | 10.88B | -2.74% | 3,205 | - |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.67B | -2.07% | 241,643 | 102.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.92B | -0.10% | 166,373 | 1.43B |
| 24 | PCVX | Vaxcyte, Inc. | 9.88B | -1.53% | 155,714 | - |
| 25 | SYRE | Spyre Therapeutics, Inc. | 9.72B | -1.61% | 272,398 | - |
| 26 | SMMT | Summit Therapeutics Inc. | 9.59B | -15.27% | 13,578,606 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 8.93B | -1.30% | 41,592 | 470.03M |
| 28 | TGTX | TG Therapeutics, Inc. | 8.91B | -1.46% | 442,363 | 897.76M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 8.78B | -4.23% | 183,222 | 7.46M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.37B | -2.03% | 112,659 | 551.69M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.62B | -4.50% | 307,709 | 963.65M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.59B | -4.82% | 297,287 | 280.75M |
| 33 | CYTK | Cytokinetics, Incorporated | 7.53B | -3.74% | 446,024 | 113.29M |
| 34 | CGON | CG Oncology, Inc. | 7.46B | 12.27% | 4,903,844 | 6.17M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.28B | -4.32% | 299,341 | 5.33M |
| 36 | AXSM | Axsome Therapeutics, Inc. | 7.25B | -2.75% | 244,535 | 865.27M |
| 37 | IMVT | Immunovant, Inc. | 7.01B | -0.94% | 195,745 | - |
| 38 | ORKA | Oruka Therapeutics, Inc. | 6.89B | -3.63% | 514,614 | - |
| 39 | KOD | Kodiak Sciences Inc. | 6.73B | -7.19% | 419,412 | - |
| 40 | BLTE | Belite Bio, Inc | 6.64B | 0.27% | 57,401 | - |
| 41 | TWST | Twist Bioscience Corporation | 6.61B | -5.58% | 1,007,292 | 459.43M |
| 42 | IBRX | ImmunityBio, Inc. | 6.47B | 1.00% | 5,986,799 | 182.57M |
| 43 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.44B | -4.63% | 502,447 | 450.82M |
| 44 | CAI | Caris Life Sciences, Inc. | 6.17B | -6.68% | 1,091,737 | 1.05B |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.15B | -0.47% | 43,479 | 253.83M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.11B | -0.40% | 170,785 | 670.78M |
| 47 | MANE | Veradermics, Incorporated | 5.44B | -0.51% | 147,972 | - |
| 48 | ERAS | Erasca, Inc. | 5.35B | -2.75% | 1,679,303 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.27B | 0.03% | 541,877 | 570.00K |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.18B | -2.38% | 118,999 | 1.16B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.05B | -2.42% | 155,863 | 2.72M |
| 52 | EWTX | Edgewise Therapeutics, Inc. | 4.83B | -3.88% | 310,305 | - |
| 53 | COGT | Cogent Biosciences, Inc. | 4.83B | -2.77% | 368,078 | - |
| 54 | IONS | Ionis Pharmaceuticals, Inc. | 4.81B | -0.67% | 1,530,148 | 960.09M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.80B | -1.24% | 274,079 | 651.03M |
| 56 | TNGX | Tango Therapeutics, Inc. | 4.22B | -2.27% | 424,779 | 53.81M |
| 57 | DFTX | Definium Therapeutics, Inc. | 4.18B | -4.93% | 429,460 | - |
| 58 | CRSP | CRISPR Therapeutics AG | 4.03B | -1.59% | 585,639 | 25.17M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 3.91B | -1.78% | 299,774 | 7.50M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.90B | -2.43% | 331,747 | 10.35M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 3.90B | -1.57% | 179,119 | 682.20M |
| 62 | ABCL | AbCellera Biologics Inc. | 3.66B | -1.57% | 829,988 | 67.85M |
| 63 | IRON | Disc Medicine, Inc. | 3.57B | -2.01% | 228,829 | - |
| 64 | IOVA | Iovance Biotherapeutics, Inc. | 3.55B | -1.03% | 3,118,787 | 378.98M |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.54B | -0.56% | 101,726 | 2.26M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.52B | -1.89% | 259,498 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.48B | -6.57% | 1,188,252 | - |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.48B | -0.71% | 622,318 | 26.31M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -2.67% | 451,699 | 508.68M |
| 70 | ACAD | Acadia Pharmaceuticals Inc. | 3.35B | 3.28% | 527,308 | 1.20B |
| 71 | LEGN | Legend Biotech Corporation | 3.29B | -2.97% | 761,765 | 1.36B |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.13B | -2.68% | 594,723 | - |
| 73 | ADMA | ADMA Biologics, Inc. | 3.09B | 1.97% | 1,047,625 | 519.15M |
| 74 | CELC | Celcuity Inc. | 3.06B | -3.13% | 257,064 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -0.97% | 122,420 | 36.54M |
| 76 | TLX | Telix Pharmaceuticals Limited | 3.02B | -2.17% | 64,946 | 890.79M |
| 77 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.05% | 288,483 | 21.38M |
| 78 | VCEL | Vericel Corporation | 2.99B | 2.70% | 266,271 | 324.17M |
| 79 | MBX | MBX Biosciences, Inc. | 2.72B | -2.04% | 48,710 | - |
| 80 | ZLAB | Zai Lab Limited | 2.72B | -1.79% | 229,867 | 441.73M |
| 81 | XNCR | Xencor, Inc. | 2.71B | -2.48% | 272,523 | 200.49M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.46B | -2.07% | 271,026 | 100.00M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.42B | 0.30% | 276,295 | 25.94M |
| 84 | PHVS | Pharvaris N.V. | 2.32B | -0.84% | 98,541 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.27B | 0.42% | 112,522 | 158.00K |
| 86 | PVLA | Palvella Therapeutics, Inc. | 2.20B | -1.37% | 78,183 | - |
| 87 | BEAM | Beam Therapeutics Inc. | 2.17B | -4.51% | 784,070 | 146.64M |
| 88 | LKFT | Lakefront Biotherapeutics NV | 2.17B | 1.74% | 114,695 | 1.13B |
| 89 | IMNM | Immunome, Inc. | 2.16B | -2.61% | 217,299 | 4.02M |
| 90 | BHVN | Biohaven Ltd. | 2.12B | 1.56% | 707,516 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | -1.14% | 262,383 | 321.74M |
| 92 | REPL | Replimune Group, Inc. | 2.06B | -0.82% | 708,901 | - |
| 93 | SEPN | Septerna, Inc. | 1.99B | -1.65% | 126,119 | 96.27M |
| 94 | VERA | Vera Therapeutics, Inc. | 1.99B | -2.24% | 267,876 | 10.28M |
| 95 | TRAX | First Tracks Biotherapeutics, Inc. | 1.97B | -0.36% | 135,723 | - |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.96B | 0.13% | 486,549 | 213.00M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | -1.39% | 211,734 | 989.36M |
| 98 | FTRE | Fortrea Holdings Inc. | 1.94B | -0.30% | 244,428 | 2.67B |
| 99 | COAG | Hemab Therapeutics Holdings, Inc. | 1.91B | 0.17% | 139,446 | - |
| 100 | ZBIO | Zenas BioPharma, Inc. | 1.90B | 0.21% | 123,497 | 11.00M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -2.78% | 630,262 | - |
| 102 | MAZE | Maze Therapeutics, Inc. | 1.87B | -0.41% | 198,181 | 20.00M |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | -1.85% | 109,003 | 140.84M |
| 104 | ZYME | Zymeworks Inc. | 1.84B | 1.52% | 260,348 | 265.97M |
| 105 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | -8.79% | 10,803,762 | 68.23M |
| 106 | LYCA | Lycia Therapeutics, Inc. | 1.79B | -0.56% | 100,632 | 4.44M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.77B | 1.42% | 119,059 | 28.21M |
| 108 | VIR | Vir Biotechnology, Inc. | 1.70B | -0.25% | 1,450,895 | 302.80M |
| 109 | KLRA | Kailera Therapeutics, Inc. | 1.69B | -1.96% | 107,723 | - |
| 110 | NRIX | Nurix Therapeutics, Inc. | 1.67B | -1.49% | 658,802 | 701.94M |
| 111 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | -3.89% | 560,298 | 1.96B |
| 112 | RARE | Ultragenyx Pharmaceutical Inc. | 1.63B | 0.00% | 1,236,167 | 730.00M |
| 113 | BRVE | Braveheart Bio, Inc. | 1.60B | 0.00% | 235,596 | - |
| 114 | WWB | Windward Bio Group AG | 1.59B | -4.04% | 159,113 | - |
| 115 | MESO | Mesoblast Limited | 1.58B | -4.81% | 48,002 | 120.25M |
| 116 | QURE | uniQure N.V. | 1.58B | -5.50% | 263,954 | 20.17M |
| 117 | PGEN | Precigen, Inc. | 1.56B | -4.19% | 1,087,577 | 156.94M |
| 118 | SLS | SELLAS Life Sciences Group, Inc. | 1.54B | -4.07% | 3,035,337 | - |
| 119 | KRSA | Korsana Biosciences, Inc. | 1.53B | 6.22% | 122,156 | - |
| 120 | IMCR | Immunocore Holdings plc | 1.52B | -1.80% | 49,815 | 429.30M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.49B | -3.75% | 73,529 | 20.00M |
| 122 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -2.54% | 161,476 | 6.13M |
| 123 | NBTX | Nanobiotix S.A. | 1.48B | -5.56% | 34,045 | 13.15M |
| 124 | GENB | Generate Biomedicines, Inc. | 1.41B | -9.61% | 551,514 | 21.07M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.40B | 2.89% | 2,550,881 | 52.89M |
| 126 | NUVB | Nuvation Bio Inc. | 1.39B | -1.25% | 1,468,626 | 201.73M |
| 127 | LBRX | LB Pharmaceuticals Inc | 1.39B | -0.30% | 173,262 | - |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.38B | 3.29% | 898,231 | - |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.38B | -0.22% | 90,568 | - |
| 130 | GPCR | Structure Therapeutics Inc. | 1.36B | -4.70% | 150,873 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.35B | -1.73% | 162,490 | 60.04M |
| 132 | URGN | UroGen Pharma Ltd. | 1.35B | 5.18% | 1,631,560 | 250.25M |
| 133 | AVLN | Avalyn Pharma Inc. | 1.35B | 0.15% | 113,919 | - |
| 134 | ABSI | Absci Corporation | 1.34B | -7.87% | 3,667,176 | 1.49M |
| 135 | NVAX | Novavax, Inc. | 1.34B | -4.52% | 1,543,612 | 411.65M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 0.37% | 589,652 | 5.49M |
| 137 | MLYS | Mineralys Therapeutics, Inc. | 1.34B | -1.30% | 194,070 | - |
| 138 | OCUL | Ocular Therapeutix, Inc. | 1.34B | -2.09% | 1,249,509 | 50.38M |
| 139 | INVA | Innoviva, Inc. | 1.33B | -1.42% | 160,342 | 438.32M |
| 140 | MNKD | MannKind Corporation | 1.28B | -3.39% | 944,360 | 413.37M |
| 141 | GHRS | GH Research PLC | 1.26B | -3.53% | 194,378 | - |
| 142 | NKTR | Nektar Therapeutics | 1.25B | -2.09% | 142,088 | 52.19M |
| 143 | SLN | Silence Therapeutics plc | 1.23B | 0.00% | 111,254 | 456.00K |
| 144 | OMER | Omeros Corporation | 1.23B | -2.63% | 249,274 | 38.42M |
| 145 | KARD | Kardigan, Inc. | 1.23B | -4.70% | 122,564 | - |
| 146 | SVRA | Savara Inc. | 1.22B | -2.37% | 1,018,630 | - |
| 147 | VOR | Vor Biopharma Inc. | 1.20B | 0.26% | 226,368 | - |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -5.93% | 118,564 | 2.00M |
| 149 | AAPG | Ascentage Pharma Group International | 1.14B | -6.70% | 9,169 | 94.61M |
| 150 | DRTS | Alpha Tau Medical Ltd. | 1.12B | -9.01% | 1,346,281 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.10B | -7.48% | 220,543 | - |
| 152 | JBIO | Jade Biosciences, Inc. | 1.06B | -4.71% | 310,521 | - |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.05B | -1.44% | 395,447 | - |
| 154 | VSTM | Verastem, Inc. | 1.01B | -2.20% | 628,864 | 100.30M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.01B | -5.76% | 167,545 | - |
| 156 | SGP | SpyGlass Pharma, Inc. | 1.00B | -8.76% | 66,365 | - |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 939.64M | 2.40% | 167,589 | 99.00K |
| 158 | AKTS | Aktis Oncology, Inc. | 925.69M | -0.18% | 130,620 | 12.39M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 899.20M | 0.19% | 209,159 | - |
| 160 | PHAR | Pharming Group N.V. | 882.68M | -0.95% | 8,304 | 386.75M |
| 161 | MGTX | MeiraGTx Holdings plc | 880.55M | -1.85% | 131,081 | 401.91M |
| 162 | CTY | City Therapeutics, Inc. | 853.33M | -5.25% | 68,054 | 14.34M |
| 163 | IMTX | Immatics N.V. | 846.11M | -3.13% | 184,582 | 49.33M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 841.34M | -3.20% | 297,898 | - |
| 165 | RIGL | Rigel Pharmaceuticals, Inc. | 839.44M | 0.27% | 41,913 | 288.21M |
| 166 | BBTX | Bambusa Therapeutics, Inc. | 827.53M | 0.96% | 23,613 | - |
| 167 | IVA | Inventiva S.A. | 827.45M | -6.39% | 1,074,562 | 2.81M |
| 168 | SNDX | Syndax Pharmaceuticals, Inc. | 822.86M | -3.28% | 644,402 | 289.68M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 803.31M | -1.40% | 257,052 | - |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 799.20M | 0.28% | 377,385 | 38.54M |
| 171 | GLUE | Monte Rosa Therapeutics, Inc. | 796.40M | -0.53% | 212,610 | 70.33M |
| 172 | ARDX | Ardelyx, Inc. | 775.48M | -0.16% | 904,820 | 468.22M |
| 173 | PRME | Prime Medicine, Inc. | 756.62M | -0.70% | 1,833,388 | 7.06M |
| 174 | OBX | Obsidian Therapeutics, Inc. | 754.25M | -2.79% | 141,279 | - |
| 175 | AURA | Aura Biosciences, Inc. | 746.21M | 0.84% | 186,620 | - |
| 176 | SLDB | Solid Biosciences Inc. | 745.56M | -2.34% | 231,614 | - |
| 177 | SGMT | Sagimet Biosciences Inc. | 733.66M | 0.59% | 183,792 | - |
| 178 | OABI | OmniAb, Inc. | 710.34M | -0.81% | 304,759 | 40.21M |
| 179 | ANNX | Annexon, Inc. | 705.83M | -5.61% | 751,047 | - |
| 180 | APMD | Apnimed, Inc. | 693.57M | -1.54% | 91,905 | 108.80M |
| 181 | ATTO | Attovia Therapeutics, Inc. | 686.59M | -0.59% | 28,505 | 1.44M |
| 182 | QUIT | Achieve Life Sciences, Inc. | 680.56M | -2.14% | 242,734 | - |
| 183 | KURA | Kura Oncology, Inc. | 679.90M | -4.76% | 806,158 | 79.31M |
| 184 | FDMT | 4D Molecular Therapeutics, Inc. | 676.27M | -1.92% | 251,279 | 96.06M |
| 185 | ANL | Adlai Nortye Group Ltd. | 666.84M | -2.40% | 31,637 | 18.06M |
| 186 | JANX | Janux Therapeutics, Inc. | 663.84M | -4.57% | 193,701 | 23.29M |
| 187 | ALMS | Alumis Inc. | 660.79M | -9.11% | 671,533 | 7.24M |
| 188 | NVCT | Nuvectis Pharma, Inc. | 658.03M | -5.46% | 114,077 | - |
| 189 | IMMX | Immix Biopharma, Inc. | 657.93M | 0.13% | 369,396 | - |
| 190 | BCAX | Bicara Therapeutics Inc. | 655.24M | -1.50% | 151,045 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 649.97M | -3.06% | 77,621 | - |
| 192 | CGEM | Cullinan Therapeutics, Inc. | 646.61M | -3.11% | 236,016 | - |
| 193 | DBVT | DBV Technologies S.A. | 645.17M | -5.40% | 24,435 | 3.74M |
| 194 | AVBP | ArriVent BioPharma, Inc. | 639.56M | -4.96% | 122,118 | 5.00M |
| 195 | OLMA | Olema Oncology, Inc. | 638.65M | -3.57% | 549,213 | - |
| 196 | GERN | Geron Corporation | 626.72M | 0.60% | 3,159,279 | 217.52M |
| 197 | ABUS | Arbutus Biopharma Corporation | 623.90M | -0.49% | 578,371 | 181.49M |
| 198 | SRZN | Surrozen, Inc. | 606.83M | 0.71% | 47,911 | 10.53M |
| 199 | CLYM | Climb Bio, Inc. | 600.60M | -1.30% | 129,433 | - |
| 200 | IAM | Iambic Therapeutics, Inc. | 599.62M | -3.44% | 250,010 | 18.25M |
| 201 | SANA | Sana Biotechnology, Inc. | 581.29M | -3.96% | 1,800,651 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 581.24M | -4.03% | 84,500 | 15.00M |
| 203 | WVE | Wave Life Sciences, Inc. | 577.88M | -6.39% | 796,359 | 70.92M |
| 204 | HELP | Helus Pharma Inc. | 577.18M | -10.94% | 10,846,531 | - |
| 205 | ACRS | Aclaris Therapeutics, Inc. | 563.87M | -9.31% | 6,226,229 | 6.40M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 562.91M | 4.19% | 703,331 | 147.76M |
| 207 | OBIO | Orchestra BioMed Holdings, Inc. | 561.17M | -1.66% | 321,553 | 31.21M |
| 208 | VALN | Valneva SE | 553.44M | 2.65% | 8,544 | 163.30M |
| 209 | ETRA | Electra Therapeutics, Inc. | 551.09M | -0.68% | 151,321 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 543.82M | -12.70% | 1,409,466 | 130.75M |
| 211 | ENTX | Entera Bio Ltd. | 536.27M | -0.98% | 104,639 | 42.00K |
| 212 | INDP | Indaptus Therapeutics, Inc. | 532.93M | 9.46% | 204,848 | - |
| 213 | GYRE | Gyre Therapeutics, Inc. | 519.89M | 10.21% | 241,254 | 110.06M |
| 214 | EPRX | Eupraxia Pharmaceuticals Inc. | 513.63M | -4.66% | 163,333 | - |
| 215 | RGNX | REGENXBIO Inc. | 501.87M | -0.65% | 245,150 | 153.91M |
| 216 | NGNE | Neurogene Inc. | 501.38M | 1.21% | 93,528 | 925.00K |
| 217 | OVID | Ovid Therapeutics Inc. | 494.48M | 3.15% | 863,311 | 1.45M |
| 218 | MNPR | Monopar Therapeutics Inc. | 493.59M | 1.16% | 82,031 | - |
| 219 | CAPR | Capricor Therapeutics, Inc. | 486.07M | -12.28% | 2,276,118 | 11.13M |
| 220 | OCS | Oculis Holding AG | 480.58M | 1.90% | 68,861 | 1.12M |
| 221 | STTK | Shattuck Labs, Inc. | 477.64M | 0.86% | 480,838 | 1.00M |
| 222 | MDXG | MiMedx Group, Inc. | 464.04M | -0.93% | 301,942 | 303.73M |
| 223 | CADL | Candel Therapeutics, Inc. | 462.83M | -4.84% | 1,483,600 | - |
| 224 | PHAT | Phathom Pharmaceuticals, Inc. | 461.49M | -4.13% | 283,636 | 274.88M |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 459.72M | -3.07% | 66,540 | - |
| 226 | ARVN | Arvinas, Inc. | 446.61M | 0.00% | 376,665 | 275.30M |
| 227 | BLSM | BlossomHill Therapeutics, Inc. | 446.26M | 0.14% | 31,252 | - |
| 228 | CTMX | CytomX Therapeutics, Inc. | 443.64M | -0.25% | 615,201 | 14.03M |
| 229 | FENC | Fennec Pharmaceuticals Inc. | 442.37M | 7.83% | 472,335 | 66.37M |
| 230 | ASMB | Assembly Biosciences, Inc. | 436.17M | 0.85% | 123,968 | 67.01M |
| 231 | AVTX | Avalo Therapeutics, Inc. | 435.99M | -2.84% | 276,314 | 59.00K |
| 232 | SLBT | SL Science Holding Limited | 423.42M | 2.13% | 8,900 | 3.27M |
| 233 | TECX | Tectonic Therapeutic, Inc. | 411.61M | -0.40% | 126,478 | - |
| 234 | PRTA | Prothena Corporation plc | 410.28M | -2.08% | 54,339 | 52.74M |
| 235 | MPLT | MapLight Therapeutics, Inc. | 392.92M | -2.48% | 111,473 | - |
| 236 | PBYI | Puma Biotechnology, Inc. | 389.81M | -2.96% | 84,429 | 231.83M |
| 237 | CRMD | CorMedix Inc. | 388.14M | 4.72% | 1,330,843 | 412.49M |
| 238 | CTNM | Contineum Therapeutics, Inc. | 386.38M | -0.20% | 69,931 | - |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 385.53M | -1.41% | 725,261 | 122.14M |
| 240 | IRD | Opus Genetics, Inc. | 384.68M | 0.00% | 157,061 | 7.91M |
| 241 | ALEC | Alector, Inc. | 383.36M | 1.38% | 726,548 | 173.47M |
| 242 | RZLT | Rezolute, Inc. | 381.85M | -0.41% | 2,425,514 | - |
| 243 | RLMD | Relmada Therapeutics, Inc. | 378.23M | -15.80% | 777,700 | - |
| 244 | CCCC | C4 Therapeutics, Inc. | 355.87M | -1.81% | 629,765 | 32.28M |
| 245 | LYEL | Lyell Immunopharma, Inc. | 352.80M | 0.35% | 62,322 | 15.00K |
| 246 | ASPE | Aspen Neuroscience, Inc. | 352.29M | -3.77% | 67,798 | - |
| 247 | PRLD | Prelude Therapeutics Incorporated | 348.12M | -2.03% | 67,299 | 21.57M |
| 248 | TRXB | TRex Bio, Inc. | 344.06M | -6.51% | 46,803 | - |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 342.90M | -0.70% | 96,009 | - |
| 250 | PROK | ProKidney Corp. | 323.55M | 2.39% | 807,800 | 775.00K |
| 251 | SCTX | Scribe Therapeutics Inc. | 323.55M | 4.43% | 142,221 | 14.83M |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 318.78M | -0.41% | 34,002 | 65.26M |
| 253 | YDES | YD Bio Limited | 318.74M | -7.79% | 51,015 | 1.24M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 316.55M | -0.64% | 95,527 | 16.96M |
| 255 | BNTC | Benitec Biopharma Inc. | 316.40M | -3.10% | 30,536 | - |
| 256 | GALT | Galectin Therapeutics Inc. | 312.13M | 1.48% | 94,921 | - |
| 257 | EVMN | Evommune, Inc. | 311.57M | -1.25% | 175,840 | 10.00M |
| 258 | VCRE | Vicore Pharma Holding AB (publ) | 311.15M | 3.76% | 9,566 | 383.48K |
| 259 | ALT | Altimmune, Inc. | 310.37M | -3.04% | 2,692,875 | 26.00K |
| 260 | EDIT | Editas Medicine, Inc. | 309.45M | -7.60% | 919,114 | 49.83M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 306.89M | -2.65% | 971,984 | - |
| 262 | KYTX | Kyverna Therapeutics, Inc. | 305.99M | -4.16% | 294,255 | - |
| 263 | EIKN | Eikon Therapeutics, Inc. | 305.61M | -5.69% | 162,795 | - |
| 264 | AGMB | AgomAb Therapeutics NV | 301.40M | -3.77% | 33,287 | - |
| 265 | IKT | Inhibikase Therapeutics, Inc. | 300.25M | -1.64% | 80,369 | 1.00 |
| 266 | AUTL | Autolus Therapeutics plc | 299.63M | -3.85% | 602,348 | 137.43M |
| 267 | AGEN | Agenus Inc. | 295.01M | -3.12% | 165,081 | 133.95M |
| 268 | IPSC | Century Therapeutics, Inc. | 293.28M | -2.12% | 233,007 | 109.16M |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 292.96M | -0.86% | 1,715,890 | 424.00K |
| 270 | DTIL | Precision BioSciences, Inc. | 288.00M | -0.26% | 71,501 | 45.04M |
| 271 | PEPG | PepGen Inc. | 287.77M | -4.70% | 1,286,626 | - |
| 272 | FULC | Fulcrum Therapeutics, Inc. | 284.52M | -1.19% | 474,424 | 80.00M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 274.77M | 3.04% | 101,827 | 114.70K |
| 274 | ALLO | Allogene Therapeutics, Inc. | 273.78M | -5.78% | 3,006,321 | 4.64M |
| 275 | TTRX | Turn Therapeutics Inc. | 269.04M | -5.83% | 77,707 | - |
| 276 | LXEO | Lexeo Therapeutics, Inc. | 264.18M | 12.20% | 30,602,724 | - |
| 277 | INO | Inovio Pharmaceuticals, Inc. | 260.48M | 1.40% | 2,865,756 | 298.90K |
| 278 | CUVL | Clinuvel Pharmaceuticals Limited | 259.42M | 0.00% | 4,903 | 65.05M |
| 279 | OCGN | Ocugen, Inc. | 256.52M | -8.67% | 3,508,597 | 4.78M |
| 280 | CAMP | Camp4 Therapeutics Corporation | 256.04M | 7.37% | 40,239 | 5.32M |
| 281 | QTTB | Q32 Bio Inc. | 255.85M | -1.84% | 80,259 | 53.74M |
| 282 | PLX | Protalix BioTherapeutics, Inc. | 255.49M | -0.66% | 427,716 | 84.69M |
| 283 | ARCT | Arcturus Therapeutics Holdings Inc. | 252.20M | 4.67% | 407,069 | 30.51M |
| 284 | CABA | Cabaletta Bio, Inc. | 251.31M | -8.98% | 2,274,519 | - |
| 285 | RCKT | Rocket Pharmaceuticals, Inc. | 249.00M | -3.04% | 582,718 | - |
| 286 | FTH | Faeth Therapeutics, Inc. | 248.84M | -3.99% | 248,850 | - |
| 287 | DRUG | Bright Minds Biosciences Inc. | 233.05M | 2.81% | 50,704 | - |
| 288 | IMRX | Immuneering Corporation | 230.23M | -4.18% | 264,883 | - |
| 289 | VNDA | Vanda Pharmaceuticals Inc. | 229.78M | -4.76% | 253,907 | 229.28M |
| 290 | LCTX | Lineage Cell Therapeutics, Inc. | 224.54M | -3.78% | 862,972 | 10.84M |
| 291 | BCYC | Bicycle Therapeutics plc | 221.15M | -6.38% | 189,427 | 83.53M |
| 292 | VTVT | vTv Therapeutics Inc. | 219.93M | -10.23% | 10,305 | 36.84M |
| 293 | NGEN | NervGen Pharma Corp. | 215.05M | 6.38% | 1,016,969 | - |
| 294 | ACIU | AC Immune SA | 207.80M | -1.88% | 30,062 | 23.75M |
| 295 | VOGX | Vogenx, Inc. | 204.85M | -17.28% | 106,084 | - |
| 296 | GLSI | Greenwich LifeSciences, Inc. | 202.56M | -7.63% | 101,685 | - |
| 297 | KROS | Keros Therapeutics, Inc. | 198.79M | -1.65% | 62,920 | 40.76M |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 197.73M | -0.25% | 766,150 | 251.00K |
| 299 | CGEN | Compugen Ltd. | 193.24M | -2.86% | 109,137 | 75.93M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 192.17M | -0.79% | 17,561 | 1.03M |
| 301 | PALI | Palisade Bio, Inc. | 190.03M | -5.36% | 510,015 | 500.00K |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 188.58M | 4.50% | 39,661 | 1.44M |
| 303 | MDWD | MediWound Ltd. | 185.20M | 0.47% | 57,359 | 10.01M |
| 304 | TRDA | Entrada Therapeutics, Inc. | 184.91M | -0.49% | 204,535 | 3.98M |
| 305 | KRRO | Korro Bio, Inc. | 181.45M | -2.87% | 17,708 | 1.29M |
| 306 | PYXS | Pyxis Oncology, Inc. | 179.41M | -5.06% | 416,507 | 11.04M |
| 307 | PRQR | ProQR Therapeutics N.V. | 178.52M | -10.28% | 287,067 | 23.46M |
| 308 | ANTX | AN2 Therapeutics, Inc. | 177.77M | 2.97% | 73,330 | - |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 177.17M | -1.88% | 55,718 | 7.15M |
| 310 | ACOG | Alpha Cognition Inc. | 176.18M | -2.53% | 56,015 | 20.20M |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 172.20M | 6.74% | 213,430 | 2.00M |
| 312 | IFRX | InflaRx N.V. | 171.68M | -0.43% | 229,522 | -38.53K |
| 313 | ELDN | Eledon Pharmaceuticals, Inc. | 169.93M | -4.96% | 420,948 | - |
| 314 | IVVD | Invivyd, Inc. | 164.39M | -4.19% | 1,381,126 | 60.69M |
| 315 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 163.15M | -4.91% | 309,229 | - |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 161.16M | -3.53% | 612,133 | 26.87M |
| 317 | RNA | Atrium Therapeutics, Inc. | 153.70M | -5.13% | 80,048 | 38.82M |
| 318 | VRXA | Veraxa Biotech AG | 148.48M | -5.41% | 31,962 | 29.54K |
| 319 | HUMA | Humacyte, Inc. | 148.21M | -4.46% | 1,821,203 | 2.40M |
| 320 | YARW | Yarrow Bioscience, Inc. | 147.80M | -11.90% | 114,467 | - |
| 321 | STRO | Sutro Biopharma, Inc. | 147.34M | -9.62% | 32,685 | 45.11M |
| 322 | TARA | Protara Therapeutics, Inc. | 147.15M | -5.53% | 215,930 | - |
| 323 | SION | Sionna Therapeutics, Inc. | 145.66M | -3.30% | 199,941 | - |
| 324 | ABEO | Abeona Therapeutics Inc. | 143.15M | 3.51% | 1,044,543 | 39.01M |
| 325 | ARMP | Armata Pharmaceuticals, Inc. | 142.08M | -1.29% | 64,802 | 7.56M |
| 326 | FATE | Fate Therapeutics, Inc. | 139.20M | -10.55% | 1,129,272 | 4.75M |
| 327 | MSLE | Satellos Bioscience Inc. | 138.33M | -2.19% | 13,414 | - |
| 328 | ENGN | enGene Therapeutics Inc. | 137.38M | -14.94% | 1,157,560 | - |
| 329 | UPB | Upstream Bio, Inc. | 136.48M | -10.43% | 743,741 | 2.87M |
| 330 | NTHI | NeOnc Technologies Holdings, Inc. | 135.52M | -0.61% | 127,928 | 39.99K |
| 331 | CNTN | Canton Strategic Holdings, Inc. | 134.66M | -1.17% | 242,710 | 4.55M |
| 332 | MENS | Jyong Biotech Ltd. | 132.14M | 1.14% | 21,763 | - |
| 333 | ALXO | ALX Oncology Holdings Inc. | 130.67M | -9.13% | 391,057 | - |
| 334 | MGNX | MacroGenics, Inc. | 129.10M | -8.18% | 241,446 | 140.81M |
| 335 | IPHA | Innate Pharma S.A. | 126.78M | 2.17% | 28,808 | 11.21M |
| 336 | LENZ | LENZ Therapeutics, Inc. | 126.47M | -2.54% | 375,047 | 12.36M |
| 337 | CMPX | Compass Therapeutics, Inc. | 125.38M | -10.03% | 665,235 | 850.00K |
| 338 | PYPD | PolyPid Ltd. | 124.71M | -1.92% | 94,868 | - |
| 339 | CDXS | Codexis, Inc. | 121.65M | -4.31% | 371,464 | 88.34M |
| 340 | SPRB | Spruce Biosciences, Inc. | 121.11M | -2.70% | 53,234 | 697.00K |
| 341 | FHTX | Foghorn Therapeutics Inc. | 115.13M | -7.25% | 157,739 | 112.13M |
| 342 | NERV | Minerva Neurosciences, Inc. | 113.13M | -1.30% | 52,433 | - |
| 343 | ADAG | Adagene Inc. | 112.80M | -1.75% | 104,032 | 9.29M |
| 344 | OKUR | OnKure Therapeutics, Inc. | 112.19M | 5.32% | 479,491 | - |
| 345 | VYGR | Voyager Therapeutics, Inc. | 106.10M | -1.45% | 195,836 | 25.11M |
| 346 | ZURA | Zura Bio Limited | 104.51M | -12.50% | 1,643,267 | - |
| 347 | CUE | Cue Biopharma, Inc. | 103.37M | -11.72% | 91,439 | 37.66M |
| 348 | ICCC | ImmuCell Corporation | 102.17M | 4.65% | 34,408 | 33.21M |
| 349 | IMUX | Immunic, Inc. | 100.97M | -1.60% | 81,732 | - |
| 350 | MOLN | Molecular Partners AG | 100.75M | -8.21% | 3,897 | 856.30K |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 100.00M | 1.13% | 448,392 | - |
| 352 | OTLK | Outlook Therapeutics, Inc. | 97.26M | -3.27% | 2,594,754 | -1.16M |
| 353 | EQ | Equillium, Inc. | 96.39M | -4.65% | 286,113 | 4.39M |
| 354 | PMVP | PMV Pharmaceuticals, Inc. | 95.15M | -0.79% | 194,234 | - |
| 355 | TVGN | Tevogen Inc. | 92.28M | -2.26% | 2,151 | - |
| 356 | VANI | Vivani Medical, Inc. | 92.01M | 0.99% | 295,725 | - |
| 357 | RTSN | Retension Pharmaceuticals, Inc. | 91.65M | -10.35% | 160,235 | - |
| 358 | NKTX | Nkarta, Inc. | 91.06M | 6.72% | 462,806 | - |
| 359 | NBP | NovaBridge Biosciences | 90.69M | -8.01% | 435,595 | - |
| 360 | NRXP | NRx Pharmaceuticals, Inc. | 90.20M | -4.79% | 362,016 | 3.39M |
| 361 | ANIX | Anixa Biosciences, Inc. | 89.00M | -2.29% | 50,900 | - |
| 362 | CBUS | Cibus, Inc. | 87.89M | 1.77% | 68,043 | 4.53M |
| 363 | PLYX | Polaryx Therapeutics, Inc. | 85.39M | -3.22% | 9,913 | - |
| 364 | KZIA | Kazia Therapeutics Limited | 84.55M | -6.80% | 78,406 | 1.27M |
| 365 | GNLX | Genelux Corporation | 83.80M | 0.27% | 96,433 | 8.00K |
| 366 | SEER | Seer, Inc. | 83.61M | -3.82% | 73,558 | 14.08M |
| 367 | RLYB | Rallybio Corporation | 82.86M | -2.10% | 13,207 | 434.00K |
| 368 | TENX | Tenax Therapeutics, Inc. | 82.29M | -5.25% | 224,586 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 82.18M | -2.72% | 196,777 | 70.00M |
| 370 | HURA | TuHURA Biosciences, Inc. | 81.25M | -8.27% | 685,945 | - |
| 371 | AVXL | Anavex Life Sciences Corp. | 79.83M | -7.75% | 945,773 | - |
| 372 | CHRS | Coherus Oncology, Inc. | 78.58M | -3.24% | 2,260,651 | 53.64M |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 77.88M | -2.15% | 708,397 | 3.03M |
| 374 | CLLS | Cellectis S.A. | 74.66M | -11.86% | 23,855 | 32.10M |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 74.24M | 1.20% | 221,452 | 6.58M |
| 376 | TLSA | Tiziana Life Sciences Ltd | 74.14M | 1.61% | 114,348 | - |
| 377 | NMRA | Neumora Therapeutics, Inc. | 71.91M | -10.77% | 697,646 | - |
| 378 | NRXS | NeurAxis, Inc. | 71.39M | -7.20% | 251,223 | 6.53M |
| 379 | COYA | Coya Therapeutics, Inc. | 70.84M | -3.51% | 37,867 | 4.69M |
| 380 | CRDF | Cardiff Oncology, Inc. | 69.72M | 23.43% | 22,303,700 | 559.00K |
| 381 | GOSS | Gossamer Bio, Inc. | 69.24M | 3.19% | 42,447 | 78.42M |
| 382 | NTRB | Nutriband Inc. | 68.38M | -7.79% | 5,451 | 1.62M |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 68.21M | -11.75% | 15,786 | 3.97M |
| 384 | MNOV | MediciNova, Inc. | 67.93M | -1.08% | 10,640 | 935.72K |
| 385 | CSBR | Champions Oncology, Inc. | 65.49M | 0.00% | 216 | 60.66M |
| 386 | PDSB | PDS Biotechnology Corporation | 65.19M | 3.08% | 3,598,891 | - |
| 387 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 64.09M | -8.26% | 250,914 | - |
| 388 | OKYO | OKYO Pharma Limited | 63.24M | -10.74% | 3,505,614 | - |
| 389 | CGTX | Cognition Therapeutics, Inc. | 61.81M | -4.40% | 163,928 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 61.49M | -1.03% | 135,818 | - |
| 391 | CNXU | Conexeu Sciences Inc. | 61.36M | -8.72% | 70,555 | - |
| 392 | MIST | Milestone Pharmaceuticals Inc. | 60.70M | -17.15% | 3,597,569 | 5.31M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 60.24M | -0.97% | 367,097 | - |
| 394 | VRCA | Verrica Pharmaceuticals Inc. | 58.75M | -3.93% | 1,209 | 22.89M |
| 395 | NORD | Nordicus Partners Corporation | 57.93M | 18.33% | 18,959 | - |
| 396 | HRTX | Heron Therapeutics, Inc. | 57.90M | -2.00% | 1,340,802 | 148.22M |
| 397 | FBIO | Fortress Biotech, Inc. | 57.70M | -7.98% | 128,965 | 69.99M |
| 398 | XBIT | XBiotech Inc. | 57.62M | -3.57% | 60,317 | - |
| 399 | BOLD | Boundless Bio, Inc. | 55.73M | -2.00% | 27,395 | - |
| 400 | CING | Cingulate Inc. | 55.55M | -11.16% | 192,677 | - |
| 401 | SPRO | Spero Therapeutics, Inc. | 55.46M | -4.75% | 180,074 | 41.56M |
| 402 | CLNN | Clene Inc. | 55.15M | -2.30% | 22,350 | 238.00K |
| 403 | TNXP | Tonix Pharmaceuticals Holding Corp. | 54.89M | -6.15% | 551,045 | 43.05M |
| 404 | AZR | Azora Therapeutics, Inc. | 54.57M | -6.60% | 3,434 | - |
| 405 | XLO | Xilio Therapeutics, Inc. | 51.79M | -2.54% | 2,314 | 55.01M |
| 406 | ATNM | Actinium Pharmaceuticals, Inc. | 51.56M | 0.00% | 158,381 | 35.09M |
| 407 | ANVS | Annovis Bio, Inc. | 49.88M | -13.16% | 1,227,033 | - |
| 408 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.64M | -8.37% | 21,303 | - |
| 409 | MREO | Mereo BioPharma Group plc | 48.39M | -1.46% | 245,630 | 800.00K |
| 410 | INKT | MiNK Therapeutics, Inc. | 47.64M | -0.05% | 3,441 | 200.00K |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 46.87M | -1.61% | 180,769 | 21.00M |
| 412 | IBO | Impact BioMedical Inc. | 45.97M | 4.67% | 6,464 | 38.00K |
| 413 | ONCY | Oncolytics Biotech Inc. | 45.62M | -3.30% | 863,814 | - |
| 414 | IBIO | iBio, Inc. | 45.26M | -3.81% | 189,668 | 1.08M |
| 415 | HYFT | MindWalk Holdings Corp. | 44.35M | -4.92% | 73,266 | 11.57M |
| 416 | RNXT | RenovoRx, Inc. | 43.79M | -12.73% | 504,475 | 2.78M |
| 417 | DWTX | Dogwood Therapeutics, Inc. | 42.78M | 0.82% | 35,087 | 100.00K |
| 418 | GANX | Gain Therapeutics, Inc. | 42.77M | -5.77% | 432,452 | - |
| 419 | IRLA | IRulya Therapeutics Inc. | 42.56M | 5.15% | 57,397 | - |
| 420 | ELTX | Elicio Therapeutics, Inc. | 42.46M | 0.00% | 84,431 | - |
| 421 | PLRX | Pliant Therapeutics, Inc. | 41.51M | -3.83% | 323,647 | - |
| 422 | ALDX | Aldeyra Therapeutics, Inc. | 40.98M | 5.47% | 645,429 | - |
| 423 | BMEA | Biomea Fusion, Inc. | 40.16M | -4.84% | 205,947 | - |
| 424 | TIL | Instil Bio, Inc. | 39.00M | -5.43% | 22,831 | - |
| 425 | ALPS | Alps Group Inc | 38.94M | -0.85% | 21,150 | 3.74M |
| 426 | CNTB | Connect Biopharma Holdings Limited | 38.78M | -9.07% | 217,649 | 2.95M |
| 427 | CRBU | Caribou Biosciences, Inc. | 38.61M | -1.24% | 589,110 | 9.44M |
| 428 | APLM | Apollomics, Inc. | 38.61M | -1.41% | 20,188 | 445.00K |
| 429 | IMA | ImageneBio, Inc. | 38.14M | -3.17% | 5,346 | 800.00K |
| 430 | HYPD | Hyperion DeFi, Inc. | 37.76M | -5.81% | 158,353 | 1.91M |
| 431 | GRCE | Grace Therapeutics, Inc. | 37.34M | -1.93% | 10,037 | - |
| 432 | KLRS | Kalaris Therapeutics, Inc. | 36.66M | -2.22% | 51,685 | - |
| 433 | RNTX | Rein Therapeutics Inc. | 35.36M | -25.76% | 5,308,083 | - |
| 434 | EYPT | EyePoint, Inc. | 35.01M | 0.56% | 2,186,152 | 2.58M |
| 435 | ATHE | Alterity Therapeutics Limited | 34.94M | 0.00% | 5,775 | 2.50M |
| 436 | VERU | Veru Inc. | 34.78M | -2.39% | 27,469 | 16.89M |
| 437 | EXOZ | eXoZymes, Inc. | 34.58M | -2.71% | 2,613 | -700.00 |
| 438 | SER | Serina Therapeutics, Inc. | 34.54M | -2.16% | 2,763 | 125.00K |
| 439 | TELO | Telomir Pharmaceuticals, Inc. | 34.53M | -4.46% | 369,421 | - |
| 440 | OSTX | OS Therapies Incorporated | 32.57M | -5.38% | 240,454 | - |
| 441 | LONA | LeonaBio, Inc. | 31.75M | -2.88% | 10,773 | - |
| 442 | NNVC | NanoViricides, Inc. | 31.65M | 0.81% | 51,661 | - |
| 443 | ACET | Adicet Bio, Inc. | 30.57M | 2.16% | 224,890 | - |
| 444 | CVM | CEL-SCI Corporation | 30.25M | 34.37% | 778,557 | - |
| 445 | BCTX | BriaCell Therapeutics Corp. | 29.70M | -0.88% | 18,142 | - |
| 446 | INMB | INmune Bio Inc. | 29.26M | -9.99% | 212,360 | 50.00K |
| 447 | NXTC | NextCure, Inc. | 29.04M | -0.86% | 8,344 | - |
| 448 | PMN | ProMIS Neurosciences, Inc. | 28.79M | -2.43% | 46,301 | - |
| 449 | CRVO | CervoMed Inc. | 28.44M | 11.24% | 353,070 | 8.73K |
| 450 | AARD | Aardvark Therapeutics, Inc. | 28.23M | -3.01% | 122,524 | - |
| 451 | PTHS | Pelthos Therapeutics Inc. | 28.14M | -1.20% | 50,216 | 51.29M |
| 452 | LITS | Lite Strategy, Inc. | 26.63M | 5.23% | 344,545 | - |
| 453 | GRDX | GridAI Technologies Corp. | 26.20M | -1.07% | 208,681 | - |
| 454 | EVAX | Evaxion A/S | 25.96M | 2.74% | 15,838 | 7.49M |
| 455 | MGX | Metagenomi Therapeutics, Inc. | 25.31M | -3.14% | 38,321 | 7.09M |
| 456 | PLRZ | Polyrizon Ltd. | 25.26M | -5.88% | 1,895 | - |
| 457 | EDSA | Edesa Biotech, Inc. | 24.19M | -7.73% | 198,555 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 24.15M | 2.20% | 29,821 | 797.92K |
| 459 | FLNA | Filana Therapeutics, Inc. | 23.76M | 11.20% | 752,527 | - |
| 460 | RNAZ | TransCode Therapeutics, Inc. | 23.70M | 6.06% | 21,547 | - |
| 461 | IMMP | Immutep Limited | 23.59M | -1.58% | 2,993 | 13.79M |
| 462 | BYSI | BeyondSpring Inc. | 22.78M | -7.85% | 23,226 | 1.88M |
| 463 | IGC | IGC Pharma, Inc. | 20.71M | 0.85% | 274,650 | 1.11M |
| 464 | ESLA | Estrella Immunopharma, Inc. | 20.00M | -10.53% | 150,322 | - |
| 465 | BSEM | BioStem Technologies, Inc. | 19.89M | 1.90% | 143,635 | 31.75M |
| 466 | CELU | Celularity Inc. | 19.64M | -3.95% | 43,225 | 18.67M |
| 467 | ATOS | Atossa Therapeutics, Inc. | 19.36M | -1.02% | 6,051 | - |
| 468 | LPCN | Lipocine Inc. | 18.93M | -0.01% | 65,657 | 3.74M |
| 469 | COCP | Cocrystal Pharma, Inc. | 18.68M | -1.04% | 19,138 | 435.00K |
| 470 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.85M | 0.41% | 9,283 | - |
| 471 | CNTX | Context Therapeutics Inc. | 16.46M | -0.94% | 822,933 | - |
| 472 | AKTX | Akari Therapeutics, Plc | 16.41M | 5.59% | 11,320 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 15.69M | 3.44% | 6,667 | - |
| 474 | NCEL | NewcelX Ltd. | 15.65M | 3.83% | 4,705 | - |
| 475 | ABOS | Acumen Pharmaceuticals, Inc. | 15.63M | 0.98% | 943,384 | - |
| 476 | MCRB | Seres Therapeutics, Inc. | 15.34M | 7.50% | 98,130 | 2.13M |
| 477 | KTTA | Pasithea Therapeutics Corp. | 15.22M | -12.72% | 239,187 | - |
| 478 | ATYR | aTyr Pharma, Inc. | 14.76M | -5.16% | 19,505 | 190.00K |
| 479 | TVRD | Tvardi Therapeutics, Inc. | 14.67M | -6.78% | 24,680 | - |
| 480 | ACTU | Actuate Therapeutics, Inc. | 14.64M | -6.73% | 112,526 | - |
| 481 | MRKR | Marker Therapeutics, Inc. | 14.63M | 0.89% | 62,399 | 3.55M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 14.48M | -4.59% | 147,115 | 350.00K |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 14.28M | -2.82% | 77,348 | 7.11M |
| 484 | GUTS | Fractyl Health, Inc. | 13.89M | 15.88% | 522,064 | 3.00K |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 13.58M | -1.57% | 9,162 | 1.17M |
| 486 | PLUR | Pluri Inc. | 13.46M | 3.81% | 11,386 | 1.46M |
| 487 | QNTM | Quantum BioPharma Ltd. | 12.84M | -9.01% | 96,848 | - |
| 488 | PASG | Passage Bio, Inc. | 12.49M | -8.71% | 6,271 | - |
| 489 | RADX | Radiopharm Theranostics Limited | 12.42M | 5.59% | 39,245 | 8.90M |
| 490 | DARE | Daré Bioscience, Inc. | 12.39M | -4.15% | 82,231 | 1.37M |
| 491 | KYNB | Kyntra Bio, Inc. | 12.23M | -12.17% | 11,923 | 4.62M |
| 492 | BCDA | BioCardia, Inc. | 12.11M | -3.72% | 37,665 | 3.00K |
| 493 | CMMB | Chemomab Therapeutics Ltd. | 11.81M | 6.54% | 24,789 | - |
| 494 | BOLT | Bolt Biotherapeutics, Inc. | 11.80M | -1.32% | 15,453 | 4.70M |
| 495 | BIVI | BioVie Inc. | 11.74M | -3.14% | 69,967 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 11.60M | -3.34% | 8,688 | - |
| 497 | DYAI | Dyadic International, Inc. | 11.48M | -3.67% | 32,449 | 3.09M |
| 498 | HIND | Vyome Holdings, Inc. | 11.16M | 0.63% | 1,173 | 153.10K |
| 499 | ALGS | Aligos Therapeutics, Inc. | 10.81M | -17.62% | 80,846 | 33.65M |
| 500 | LSTA | Lisata Therapeutics, Inc. | 10.81M | -0.90% | 20,383 | 100.00K |